Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: A preclinical and clinical study

Pharmacological Research

Volumn 46, Issue 6, 2002, Pages 525-531

  Bertoni, Michele ^a   Oliveri, Filippo ^a   Manghetti, Marta ^a   Boccolini, Elena ^a   Bellomini, Maria Grazia ^a   Blandizzi, Corrado ^b   Bonino, Ferruccio ^a   Del Tacca, Mario ^b  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Crenotherapy; Functional dyspepsia; Gastric functions; Gastrin; Mineral water

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; BICARBONATE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; GASTRIN ANTAGONIST; MINERAL WATER; PEPSINOGEN; BENZODIAZEPINE DERIVATIVE; CARBANILAMIDE DERIVATIVE; CHOLECYSTOKININ RECEPTOR;

ADULT; AGED; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; FLUID INTAKE; HEARTBURN; HELICOBACTER INFECTION; HUMAN; MALE; NONHUMAN; PATIENT SELECTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; STOMACH DISTENSION; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH MOTILITY; STOMACH SECRETION; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; ANIMAL; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG SCREENING; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION; STATISTICS; STOMACH MUCOSA;

ADULT; AGED; ANALYSIS OF VARIANCE; ANIMALS; BENZODIAZEPINONES; BICARBONATES; DRUG EVALUATION, PRECLINICAL; DYSPEPSIA; FEMALE; GASTRIC EMPTYING; GASTRIC MUCOSA; HUMANS; MALE; MIDDLE AGED; MINERAL WATERS; PHENYLUREA COMPOUNDS; RATS; RECEPTORS, CHOLECYSTOKININ;

EID: 0036452970     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043661802002323     Document Type: Article

References (26)

1. Richter JE. Dyspepsia: Organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991; 26(Suppl 182): 11-6.
2. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GNJ. Functional gastroduodenal disorders. Gut 1999; 45(Suppl II): 37-42.
3. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145-60.
4. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med 2000; 134: 815-22.
5. Agreus L, Talley NJ. Dyspepsia: Current understanding and management. Annu Rev Med 1997; 49: 475-93.
6. Holtmann G, Talley NJ. Functional dyspepsia: Current treatment recommendations. Drugs 1993; 45: 918-30.
7. Malagelada JR. Gastrointestinal motor disturbances in functional dyspepsia. Scand J Gastroenterol 1991; 26(Suppl 182): 29-32.
8. Mansi C, Borro P, Giacomini M, Biagini R, Mele MR, Pandolfo N, Savarino V. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000; 14: 561-9.
9. Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled trials. J Clin Gastroenterol 1989; 11: 169-77.
10. Grossi F. Influence of mineral waters on functional dyspepsia. Clin Ther 1989; 129: 261-70.
11. Grassi M, Fraioli A. Dyspeptic syndrome. Aspects of physiopathology. Clin Ther 1991; 137: 199-208.
12. Anti M, Pignataro G, Armuzzi A, Valenti A, Iascone E, Marmo R, Lamazza A, Pretaroli AR, Pace V, Leo P, Castelli A, Gasbarrini G. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional dyspepsia. Hepatogastroenterology 1998; 48: 727-32.
13. Stanghellini V, Corinaldesi R, Raiti C, Rea E, Salgemini R, Paparo GF, Dominici G, Barbara L. Effect of alkaline-earth water on gastric emptying time in patients with anorganic dyspepsia. Clin Ther 1987; 121: 63-74.
14. Blandizzi C, Lazzeri G, Colucci R, Carignani D, Tognetti M, Baschiera F, Del Tacca M. CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion. Eur J Pharmacol 1999; 373: 71-84.
15. Blandizzi C, Natale G, Gherardi G, Lazzeri G, Marveggio C, Colucci R, Carignani D, Del Tacca M. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig Dis Sci 1999; 44: 2039-50.
16. Varga G, Scarpignato C. Camostate- and caerulein-induced delay of gastric emptying in the rat: Effect of CCK receptor antagonists. Eur J Pharmacol 1996; 306: 153-9.
17. Behar J, Hitchings M, Smyth RD. Calcium stimulation of gastrin and gastric secretion: Effect of small doses of calcium carbonate. Gut 1977; 18: 442-8.
18. Barclay G, Maxwell V, Grossman MI, Solomon TE. Effects of graded amounts of intragastric calcium on acid secretion, gastrin release, and gastric emptying in normal and duodenal ulcer subjects. Dig Dis Sci 1983; 28: 385-91.
19. Caldara R, Masci E, Barbieri C, Sorghi M, Piepoli V, Tittobello A. Effect of nifedipine on gastric acid secretion and gastrin release in healthy man. Eur J Clin Pharmacol 1985; 28: 677-9.
20. Grimm G, Salem G, Prager-Petz J, Pils P, Gloeckler M, Sadowsky J, Pointner H. Influence of verapamil on gastric acid secretion and gastrin release in dogs. Digestion 1985; 32: 282-7.
21. Walsh JH. Gastrointestinal hormones. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 3rd Edn. New York: Raven Press, 1994: 1-31.
22. Lin HC, Doty JE, Reedy TJ, Meyer JH. Inhibition of gastric emptying by acids depends on pH, titrable acidity, and length of intestine exposed to acid. Am J Physiol 1990; 259: G1025-30.
23. Mayer EA. The physiology of gastric storage and emptying. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 3rd Edn. New York: Raven Press, 1994: 929-76.
24. Strunz UT, Code CF, Grossman MI. Effect of gastrin on electrical activity of antrum and duodenum of dogs. Proc Soc Exp Biol Med 1979; 161: 25-7.
25. Dubois A, Castell DO. Abnormal gastric emptying response to pentagastrin in duodenal ulcer disease. Dig Dis Sci 1981; 26: 292-6.
26. Woodruff GN, Hughes J. Cholecystokinin antagonists. Annu Rev Pharmacol Toxicol 1991; 31: 469-501.